Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Immutep’s Lung Cancer Candidate Shows Encouraging Efficacy As Second-Line Treatment

Immutep Limited (NASDAQ:IMMP) announced new interim data from 2nd line non-small cell lung cancer (NSCLC) patients (Part B) in the Phase…
byVandana Singh
August 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Immutep Limited (NASDAQ:IMMP) announced new interim data from 2nd line non-small cell lung cancer (NSCLC) patients (Part B) in the Phase 2 TACTI-002 trial. 
  • Part B evaluates Immutep’s lead product candidate, eftilagimod alpha (efti or IMP321), in combination with Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in 36 patients.
  • Median overall survival (OS) was 9.7 months for those who received chemo-free therapy of efti in combination with pembrolizumab, comparable with the current standard of care chemotherapy options in this 2nd line setting.
  • Favorable sustained survival with 36.5% of patients alive at 18 months.
  • Disease Control Rate (DCR) was 36.1%, and disease control (progression-free) in 25% of patients at six months.
  • Durable responses of 10+ months in 5.6% (2/36) of patients, with both patients continuing in the trial for over 11 months and 24+ months.
  • Efti, combined with pembrolizumab, continues to be safe and well-tolerated, with no new safety signals.
  • Efti’s good safety profile to date compares favorably to the standard of care chemotherapy options.
  • Price Action: IMMP shares are down 1.77% at $2.22 during the market session on the last check Monday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Game-Changing Deal: eBay, Collectors Ink Agreement To Boost Trading Card Hobby

By Shivani Kumaresan
April 10, 9:13 AM
eBay solidifies its position in the collectibles market with a definitive agreement with Collectors, parent company of PSA. The agreement entails commercial deals and asset exchanges, promising streamlined experiences for trading card enthusiasts in the U.S. eBay and PSA are set to unveil a customer-centric product experience, including a new service for listing graded trading cards on eBay, enhancing inventory diversity.

EBAY